AtheroGenics (AGIX) regained it's compliance with NASDAQ listing requirement as the company announced that the NASDAQ Listing Qualifications Panel has granted AtheroGenics request for continued listing of its stocks on the exchange. The company filed its Form 10K on March 3, 2008, showing that the company has satisfied a NASDAQ requirement to have more than $50 million in revenue and $50 million in total assets for the fiscal year ended Dec 31, 2007.